BENEFITING: LAZAREX CANCER FOUNDATION
EVENT DATE: Nov 06, 2016
Dear Family and Friends,
On November 6, 2016, I will race in the New York City Marathon for Team for Life and the Lazarex Cancer Foundation. I am writing to ask for your financial support for this worthy cause so together we can help cancer patients access treatments that could potentially extend their lives and lead to cures for many others.
Cancer is personal to me. It has afflicted three consecutive generations of my family. Cancer was the cause of death of my maternal grandmother, my mother’s best friend, my best friend’s mother, and even my wife’s best friend’s mother. Three women in my immediate circle are breast cancer survivors. That’s a lot of cancer! The disease has touched the lives of so many people close to my heart.
I fulfilled a lifelong dream last year when I completed my first marathon in Minnesota. Training lasted four months and required a large investment of my personal time. As I prepare to run in New York City this year, I feel good knowing that those long hours I put in are helping to improve the lives of individuals who need our assistance the most.
I chose the Lazarex Cancer Foundation as the focus of my fundraising efforts because I liked the mission. Lazarex removes barriers to clinical participation for end stage cancer patients by defraying associated costs including transportation, lodging, and medical expenses not covered by insurance but necessary for clinical trial treatment.
Dana Dornsife started Lazarex after her brother-in-law, Mike Miller, was diagnosed with pancreatic cancer in 2003. Dana connected Mike with a clinical trial for an experimental cancer drug that extended his life long enough to prepare his two sons for their future without him, and for his then four year old daughter to remember him. Since then, Dana has fought tirelessly as President of the Lazarex Cancer Foundation for patient advocacy and the expansion of available resources on behalf of cancer patients who have been told they have run out of medical options and there is no hope left.
Dana’s efforts have paid off. From 2007 to 2014, Lazarex enabled over 1,000 patients with 88 different types of cancer to participate in 399 separate clinical trials. Lazarex patients have lived a total of 185,185 days through participation in FDA clinical trials AFTER they were told nothing else could be done! This equates to 507 years!
Please consider making a donation and help make a difference for these patients. I would be honored if you could support me as I race in New York City for this great cause. Please note that because Lazarex founders cover the organization’s overhead, 100% of your donation will go to program services.
You can read more about the mission of the Lazarex Cancer Foundation here: https://www.lazarex.org/